Submucosal Lifting Agent Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently published an in-depth analysis of the global Submucosal Lifting Agent Market, offering insights into key market dynamics, growth drivers, challenges, and emerging trends. This report provides exclusive data and statistics forecasting the market's trajectory from 2023 to 2030.

The global submucosal lifting agent market is forecast to expand at a CAGR of 7.0% and thereby increase from a value of US$ 1.1 Bn in 2023 to US$ 1.8 Bn by the end of 2030.

Key Insights:

Submucosal Lifting Agent Market Size in 2023: US$1.1 Bn
Projected Market Value in 2030: US$1.8 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 7.0%
Historical Market Growth Rate (CAGR 2018 to 2022): 6.5%

Submucosal Lifting Agent Market - Report Scope:

The Submucosal Lifting Agent Market encompasses a range of agents used in endoscopic procedures to lift and separate the mucosa from the underlying tissue, facilitating various diagnostic and therapeutic interventions. Market growth is driven by the increasing prevalence of gastrointestinal disorders, advancements in endoscopic techniques, and rising demand for minimally invasive procedures.

Submucosal lifting agents are vital substances used in endoscopic procedures like EMR and ESD to create separation between mucosal and submucosal layers, aiding in lesion visualization and removal in the gastrointestinal tract. They enhance diagnostic and therapeutic outcomes, minimizing perforation risk and improving precision. With the increasing prevalence of gastrointestinal diseases and the rising adoption of minimally invasive techniques, the market for these agents is growing. There are opportunities for innovation to develop agents with better capabilities and fewer adverse effects. Additionally, the growing awareness among healthcare professionals about their benefits is driving market expansion in gastrointestinal endoscopy.

Market Growth Drivers:

The global Submucosal Lifting Agent Market is primarily propelled by the growing incidence of gastrointestinal diseases, including gastrointestinal bleeding, polyps, and cancers. Additionally, the rising adoption of minimally invasive endoscopic procedures for diagnostic and therapeutic purposes further drives market growth. Technological advancements in endoscopic devices and accessories also contribute to market expansion. The Submucosal Lifting Agent Market is growing due to the rising prevalence of gastrointestinal diseases requiring endoscopic interventions, such as colorectal neoplasms and early-stage cancers. These agents are crucial for creating a submucosal cushion, enhancing lesion visualization and removal safety. Advancements in endoscopic techniques also drive market growth, with a focus on precision and safety improvement. Innovations in both endoscope design and agent formulation contribute to better procedural outcomes and patient safety, attracting healthcare providers and endoscopists to adopt these agents in various gastrointestinal procedures, thus boosting market growth.

Market Restraints:

Despite favorable market growth prospects, the Submucosal Lifting Agent Market faces challenges related to the high cost of endoscopic procedures, reimbursement issues, and limited accessibility to advanced healthcare facilities, particularly in developing regions. Moreover, concerns regarding adverse events associated with submucosal injections, such as perforation and bleeding, pose a challenge to market adoption.

Market Opportunities:

The Submucosal Lifting Agent Market presents significant opportunities driven by ongoing research and development efforts aimed at improving the safety, efficacy, and versatility of submucosal lifting agents. Innovations in formulation, delivery systems, and biocompatibility enhance the performance and safety profile of these agents, expanding their applicability across a wide range of endoscopic procedures.

Key Questions Answered in the Report:

Which regions are poised to lead the growth of the Submucosal Lifting Agent Market?
What factors influence the adoption of submucosal lifting agents in endoscopic procedures?
How are technological advancements reshaping the competitive landscape of the Submucosal Lifting Agent Market?
Who are the key players driving innovation and market expansion in the Submucosal Lifting Agent segment?
What are the emerging trends and future prospects in the global Submucosal Lifting Agent Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Submucosal Lifting Agent Market, including Laborie, STERIS, Olympus America, Medtronic, Boston Scientific Corporation, Omnimed Ltd(TM), COSMO PHARMACEUTICALS, Micro-Tech Endoscopy, Ovesco Endoscopy AG, focus on product innovation, strategic collaborations, and geographic expansion to maintain market dominance. These companies invest significantly in research and development to introduce advanced submucosal lifting agents and endoscopic accessories, catering to evolving clinical needs and enhancing patient outcomes. Collaboration with healthcare providers, academic institutions, and regulatory agencies facilitates product development and market penetration strategies.

Key Companies Profiled:

Laborie
STERIS
Olympus America
Medtronic
Boston Scientific Corporation
Omnimed Ltd(TM)
COSMO PHARMACEUTICALS
Micro-Tech Endoscopy
Ovesco Endoscopy AG

Submucosal Lifting Agent Market Research Segmentation:

By Ingredient:

Poloxamer 188 and Polyoxyl-15-hydroxystearate
Gellan gum and Polysaccharide
Sodium Hyaluronate
Cellulose
Absorbable Starch Polymers
Poloxamers

By Type:

Normal saline
Dextrose water
Hydroxypropyl methylcellulose
Hydroxyethyl starch
Hyaluronic acid
Fibrinogen mixture
Succinylated gelatin
Eleview and ORISE gel

By Application:

Polyps
Adenomas
Early-stage Cancers
Gastrointestinal Mucosal Lesions
Others

By End-use:

Hospitals
Specialty Clinics
Surgical Centers
Others

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33848

1. Executive Summary

1.1. Global Submucosal Lifting Agent Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Ingredient Lifecycle Analysis
2.4. Submucosal Lifting Agent Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Submucosal Lifting Agent Market Outlook: Ingredient
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Ingredient, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
  - 3.3.3.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 3.3.3.2. Gellan gum and Polysaccharide
  - 3.3.3.3. Sodium Hyaluronate
  - 3.3.3.4. Cellulose
  - 3.3.3.5. Absorbable Starch Polymers
  - 3.3.3.6. Poloxamers
3.4. Market Attractiveness Analysis: Ingredient
3.5. Global Submucosal Lifting Agent Market Outlook: Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
  - 3.5.3.1. Normal saline
  - 3.5.3.2. Dextrose water
  - 3.5.3.3. Hydroxypropyl methylcellulose
  - 3.5.3.4. Hydroxyethyl starch
  - 3.5.3.5. Hyaluronic acid
  - 3.5.3.6. Fibrinogen mixture
  - 3.5.3.7. Succinylated gelatin
  - 3.5.3.8. Eleview and ORISE gel
3.6. Global Submucosal Lifting Agent Market Outlook: Application
- 3.6.1. Introduction / Key Findings
- 3.6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.6.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.6.3.1. Polyps
  - 3.6.3.2. Adenomas
  - 3.6.3.3. Early-stage Cancers
  - 3.6.3.4. Gastrointestinal Mucosal Lesions
  - 3.6.3.5. Others
3.7. Market Attractiveness Analysis: Type
3.8. Global Submucosal Lifting Agent Market Outlook: End User
- 3.8.1. Introduction / Key Findings
- 3.8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.8.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.8.3.1. Hospitals
  - 3.8.3.2. Specialty Clinics
  - 3.8.3.3. Surgical Centers
  - 3.8.3.4. Others
3.9. Market Attractiveness Analysis: End User

4. Global Submucosal Lifting Agent Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia & Pacific
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Ingredient
- 5.3.3. By Type
- 5.3.4. By Application
- 5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 5.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 5.5.2. Gellan gum and Polysaccharide
- 5.5.3. Sodium Hyaluronate
- 5.5.4. Cellulose
- 5.5.5. Absorbable Starch Polymers
- 5.5.6. Poloxamers
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 5.6.1. Normal saline
- 5.6.2. Dextrose water
- 5.6.3. Hydroxypropyl methylcellulose
- 5.6.4. Hydroxyethyl starch
- 5.6.5. Hyaluronic acid
- 5.6.6. Fibrinogen mixture
- 5.6.7. Succinylated gelatin
- 5.6.8. Eleview and ORISE gel
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Polyps
- 5.7.2. Adenomas
- 5.7.3. Early-stage Cancers
- 5.7.4. Gastrointestinal Mucosal Lesions
- 5.7.5. Others
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.8.1. Hospitals
- 5.8.2. Specialty Clinics
- 5.8.3. Surgical Centers
- 5.8.4. Others
5.9. Market Attractiveness Analysis

6. Europe Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Ingredient
- 6.3.3. By Type
- 6.3.4. By Application
- 6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 6.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 6.5.2. Gellan gum and Polysaccharide
- 6.5.3. Sodium Hyaluronate
- 6.5.4. Cellulose
- 6.5.5. Absorbable Starch Polymers
- 6.5.6. Poloxamers
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 6.6.1. Normal saline
- 6.6.2. Dextrose water
- 6.6.3. Hydroxypropyl methylcellulose
- 6.6.4. Hydroxyethyl starch
- 6.6.5. Hyaluronic acid
- 6.6.6. Fibrinogen mixture
- 6.6.7. Succinylated gelatin
- 6.6.8. Eleview and ORISE gel
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Polyps
- 6.7.2. Adenomas
- 6.7.3. Early-stage Cancers
- 6.7.4. Gastrointestinal Mucosal Lesions
- 6.7.5. Others
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.8.1. Hospitals
- 6.8.2. Specialty Clinics
- 6.8.3. Surgical Centers
- 6.8.4. Others
6.9. Market Attractiveness Analysis

7. East Asia Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Ingredient
- 7.3.3. By Type
- 7.3.4. By Application
- 7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 7.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 7.5.2. Gellan gum and Polysaccharide
- 7.5.3. Sodium Hyaluronate
- 7.5.4. Cellulose
- 7.5.5. Absorbable Starch Polymers
- 7.5.6. Poloxamers
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 7.6.1. Normal saline
- 7.6.2. Dextrose water
- 7.6.3. Hydroxypropyl methylcellulose
- 7.6.4. Hydroxyethyl starch
- 7.6.5. Hyaluronic acid
- 7.6.6. Fibrinogen mixture
- 7.6.7. Succinylated gelatin
- 7.6.8. Eleview and ORISE gel
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Polyps
- 7.7.2. Adenomas
- 7.7.3. Early-stage Cancers
- 7.7.4. Gastrointestinal Mucosal Lesions
- 7.7.5. Others
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.8.1. Hospitals
- 7.8.2. Specialty Clinics
- 7.8.3. Surgical Centers
- 7.8.4. Others
7.9. Market Attractiveness Analysis

8. South Asia & Oceania Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Ingredient
- 8.3.3. By Type
- 8.3.4. By Application
- 8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 8.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 8.5.2. Gellan gum and Polysaccharide
- 8.5.3. Sodium Hyaluronate
- 8.5.4. Cellulose
- 8.5.5. Absorbable Starch Polymers
- 8.5.6. Poloxamers
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 8.6.1. Normal saline
- 8.6.2. Dextrose water
- 8.6.3. Hydroxypropyl methylcellulose
- 8.6.4. Hydroxyethyl starch
- 8.6.5. Hyaluronic acid
- 8.6.6. Fibrinogen mixture
- 8.6.7. Succinylated gelatin
- 8.6.8. Eleview and ORISE gel
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Polyps
- 8.7.2. Adenomas
- 8.7.3. Early-stage Cancers
- 8.7.4. Gastrointestinal Mucosal Lesions
- 8.7.5. Others
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.8.1. Hospitals
- 8.8.2. Specialty Clinics
- 8.8.3. Surgical Centers
- 8.8.4. Others
8.9. Market Attractiveness Analysis

9. Latin America Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Ingredient
- 9.3.3. By Type
- 9.3.4. By Application
- 9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 9.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 9.5.2. Gellan gum and Polysaccharide
- 9.5.3. Sodium Hyaluronate
- 9.5.4. Cellulose
- 9.5.5. Absorbable Starch Polymers
- 9.5.6. Poloxamers
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 9.6.1. Normal saline
- 9.6.2. Dextrose water
- 9.6.3. Hydroxypropyl methylcellulose
- 9.6.4. Hydroxyethyl starch
- 9.6.5. Hyaluronic acid
- 9.6.6. Fibrinogen mixture
- 9.6.7. Succinylated gelatin
- 9.6.8. Eleview and ORISE gel
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Polyps
- 9.7.2. Adenomas
- 9.7.3. Early-stage Cancers
- 9.7.4. Gastrointestinal Mucosal Lesions
- 9.7.5. Others
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.8.1. Hospitals
- 9.8.2. Specialty Clinics
- 9.8.3. Surgical Centers
- 9.8.4. Others
9.9. Market Attractiveness Analysis

10. Middle East & Africa Submucosal Lifting Agent Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Ingredient
- 10.3.3. By Type
- 10.3.4. By Application
- 10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 10.5.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
- 10.5.2. Gellan gum and Polysaccharide
- 10.5.3. Sodium Hyaluronate
- 10.5.4. Cellulose
- 10.5.5. Absorbable Starch Polymers
- 10.5.6. Poloxamers
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 10.6.1. Normal saline
- 10.6.2. Dextrose water
- 10.6.3. Hydroxypropyl methylcellulose
- 10.6.4. Hydroxyethyl starch
- 10.6.5. Hyaluronic acid
- 10.6.6. Fibrinogen mixture
- 10.6.7. Succinylated gelatin
- 10.6.8. Eleview and ORISE gel
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Polyps
- 10.7.2. Adenomas
- 10.7.3. Early-stage Cancers
- 10.7.4. Gastrointestinal Mucosal Lesions
- 10.7.5. Others
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.8.1. Hospitals
- 10.8.2. Specialty Clinics
- 10.8.3. Surgical Centers
- 10.8.4. Others
10.9. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Gellan gum and Polysaccharide
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Laborie
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. STERIS
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Olympus America
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Medtronic
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Boston Scientific Corporation
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Omnimed Ltd(tm)
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. COSMO PHARMACEUTICALS
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Micro-Tech Endoscopy
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Ovesco Endoscopy AG
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations